Search Results - "Kam, K M"

Mycobacterium tuberculosis Strains with Highly Discordant Rifampin Susceptibility Test Results by Van Deun, A, Barrera, L, Bastian, I, Fattorini, L, Hoffmann, H, Kam, K.M, Rigouts, L, Rüsch-Gerdes, S, Wright, A

“…The objectives of this study were to investigate the origin of highly discordant rifampin (rifampicin) (RMP) drug susceptibility test results obtained for…”
Get full text

A phase II study of concurrent cetuximab–cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma by Ma, B.B.Y., Kam, M.K.M., Leung, S.F., Hui, E.P., King, A.D., Chan, S.L., Mo, F., Loong, H., Yu, B.K.H., Ahuja, A., Chan, A.T.C.

“…Based on our previous work on the clinical activity of cetuximab in recurrent nasopharyngeal carcinoma (NPC), we evaluated the feasibility of adding cetuximab…”
Get full text

Multicentre evaluation of Ziehl-Neelsen and light-emitting diode fluorescence microscopy in China by Xia, H., Song, Y-Y., Zhao, B., Kam, K-M., O'Brien, R. J., Zhang, Z-Y., Sohn, H., Wang, W., Zhao, Y-L.

“…OBJECTIVE: To assess the feasibility of using light-emitting diode fluorescence microscopy (LED-FM) in peripheral laboratories in China.DESIGN: The performance…”
Get full text

Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation by Hui, E.P., Ma, B.B.Y., King, A.D., Mo, F., Chan, S.L., Kam, M.K.M., Loong, H.H., Ahuja, A.T., Zee, B.C.Y., Chan, A.T.C.

“…We aimed to evaluate the safety and efficacy of single-agent sunitinib in nasopharyngeal carcinoma (NPC). Eligible patients had progressive disease after prior…”
Get full text

High mortality in adults hospitalized for active tuberculosis in a low HIV prevalence setting by Lui, Grace, Wong, Rity Y K, Li, Florence, Lee, May K P, Lai, Raymond W M, Li, Timothy C M, Kam, Joseph K M, Lee, Nelson

“…This study aims to evaluate the outcomes of adults hospitalized for tuberculosis in a higher-income region with low HIV prevalence. A retrospective cohort…”
Get full text

Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079) by Ma, B. B. Y., Goh, B. C., Lim, W. T., Hui, E. P., Tan, E. H., Lopes, G. de Lima, Lo, K. W., Li, L., Loong, H., Foster, N. R., Erlichman, C., King, A. D., Kam, M. K. M., Leung, S. F., Chan, K. C., Chan, A. T. C.

“…Summary Background This study investigated the activity of MK-2206, an AKT inhibitor, in metastatic or recurrent nasopharyngeal carcinoma (NPC). Method Oral…”
Get full text

Molecular and phenotypic characterization of multidrug-resistant Mycobacterium tuberculosis isolates resistant to kanamycin, amikacin, and capreomycin in China by Zhang, Z., Liu, M., Wang, Y., Pang, Y., Kam, K. M., Zhao, Y.

“…Although second-line anti-tuberculosis (TB) injectable drugs have been widely used to improve treatment outcomes of multidrug-resistant TB (MDR-TB), little is…”
Get full text

Serogroup, Virulence, and Genetic Traits of Vibrio parahaemolyticus in the Estuarine Ecosystem of Bangladesh by Alam, Munirul, Chowdhury, Wasimul B, Bhuiyan, N.A, Islam, Atiqul, Hasan, Nur A, Nair, G. Balakrish, Watanabe, H, Siddique, A.K, Huq, Anwar, Sack, R. Bradley, Akhter, M.Z, Grim, Christopher J, Kam, K.-M, Luey, C.K.Y, Endtz, Hubert P, Cravioto, Alejandro, Colwell, Rita R

“…Forty-two strains of Vibrio parahaemolyticus were isolated from Bay of Bengal estuaries and, with two clinical strains, analyzed for virulence, phenotypic, and…”
Get full text

Determination of critical concentrations of second-line anti-tuberculosis drugs with clinical and microbiological relevance by KAM, K. M, SLOUTSKY, A, YIP, C. W, BULLED, N, SEUNG, K. J, ZIGNOL, M, ESPINAL, M, KIM, S. J

“…Reliable DST against second-line anti-tuberculosis drugs (SLDs) is crucial for the management of the increasing burden of patients affected by multidrug- and…”
Get full text

Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma—correlation with excision repair cross-complementing-1 polymorphisms by Ma, B. B. Y., Hui, E. P., Wong, S. C. C., Tung, S. Y., Yuen, K. K., King, A., Chan, S. L., Leung, S. F., Kam, M. K., Yu, B. K. H., Zee, B., Chan, A. T. C.

“…Background: Nasopharyngeal carcinoma (NPC) is a platinum-sensitive cancer and excision repair cross-complementing group 1 (ERCC1) polymorphisms have been shown…”
Get full text

First proficiency testing of second-line anti-tuberculosis drug susceptibility testing in 12 provinces of China by Jiang, G-L., Chen, X., Song, Y., Zhao, Y., Huang, H., Kam, K. M.

“…OBJECTIVE: To evaluate the performance of drug susceptibility testing (DST) against the main second-line (SL) anti-tuberculosis drugs in tuberculosis (TB)…”
Get full text

Surgical salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma: A multivariate analysis of prognostic factors by Vlantis, Alexander C., Chan, Hing Sang, Tong, Michael C. F., Yu, Brian K. H., Kam, Michael K. M., van Hasselt, C. Andrew

“…Background The purpose of this study was to identify independent prognostic factors that influenced local relapse‐free survival (LRFS) and overall survival…”
Get full text

Streptococcus suis infection in Hong Kong: an emerging infectious disease? by MA, E., CHUNG, P. H., SO, T., WONG, L., CHOI, K. M., CHEUNG, D. T., KAM, K. M., CHUANG, S. K., TSANG, T.

“…We conducted a 31-month retrospective review of all laboratory-confirmed Streptococcus suis infections admitted to public hospitals in Hong Kong. Strain…”
Get full text

Usefulness of resistant gene markers for predicting treatment outcome on second‐line anti‐tuberculosis drugs by Leung, K.L, Yip, C.W, Yeung, Y.L, Wong, K.L, Chan, W.Y, Chan, M.Y, Kam, K.M

“…Aim: Mutations in rrs [nucleotide (nt) 1401], gyrA gene (codons 90, 91 or 94), tlyA, ethA and thyA genes of Mycobacterium tuberculosis (MTB) were evaluated for…”
Get full text

Risk factors for multidrug-resistant tuberculosis in Hong Kong by LAW, W. S, YEW, W. W, CHIU LEUNG, C, KAM, K. M, TAM, C. M, CHAN, C. K, LEUNG, C. C

“…SETTING: Previous anti-tuberculosis treatment is a widely reported risk factor for multidrug-resistant tuberculosis (MDR-TB), whereas other risk factors are…”
Get full text

Peak plasma rifampicin level in tuberculosis patients with slow culture conversion by Chang, K.-C., Leung, C.-C., Yew, W.-W., Kam, K.-M., Yip, C.-W., Ma, C.-H., Tam, C.-M., Leung, E. C.-C., Law, W.-S., Leung, W.-M.

“…The clinical utility of therapeutic drug monitoring in tuberculosis has not been adequately evaluated by controlled clinical trials. To examine the…”
Get full text

Methodological issues in quantifying the magnitude of the tuberculosis problem in a prison population by RIEDER, H. L, ANDERSON, C, DARA, M, HAUER, B, HELBLING, P, KAM, K. M, ZWAHLEN, M

“…SETTING: Correctional settings and remand prisons.OBJECTIVE: To critically discuss calculations for epidemiological indicators of the tuberculosis (TB) burden…”
Get full text

Overall Survival After Concurrent Cisplatin–Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma by Chan, Anthony T. C., Leung, S. F., Ngan, Roger K. C., Teo, Peter M. L., Lau, W. H., Kwan, W. H., Hui, Edwin P., Yiu, H. Y., Yeo, Winnie, Cheung, F. Y., Yu, K. H., Chiu, K. W., Chan, D. T., Mok, Tony S. K., Yau, Stephen, Yuen, K. T., Mo, Frankie K. F., Lai, Maria M. P., Ma, Brigette B. Y., Kam, Michael K. M., Leung, Thomas W. T., Johnson, Philip J., Choi, Peter H. K., Zee, Benny C. Y.

“…This phase III randomized study compared concurrent cisplatin–radiotherapy (CRT) versus radiotherapy (RT) alone in patients with locoregionally advanced…”
Get full text

Random blinded rechecking of sputum acid-fast bacilli smear using fluorescence microscopy: 8 years' experience by Yip, C. W., Chan, M. Y., Cheung, W. F., Yu, K. W., Tang, H. S., Kam, K. M.

“…BACKGROUND: The Hong Kong TB Reference Laboratory is a high volume laboratory examining around 400 sputum acid-fast bacilli smears daily using fluorescence…”
Get full text

Prospective Randomized Study of Intensity-Modulated Radiotherapy on Salivary Gland Function in Early-Stage Nasopharyngeal Carcinoma Patients by KAM, Michael K. M, LEUNG, Sing-Fai, CHIU, Samuel K. W, CHOI, Peter H. K, TEO, Peter M. L, KWAN, Wing-Hong, CHAN, Anthony T. C, ZEE, Benny, CHAU, Ricky M. C, SUEN, Joyce J. S, MO, Frankie, LAI, Maria, HO, Rosalie, CHEUNG, Kin-Yin, YU, Brian K. H

“…This randomized trial compared the rates of delayed xerostomia between two-dimensional radiation therapy (2DRT) and intensity-modulated radiation therapy…”
Get full text